期刊文献+

Twist和ZO-1在卵巢癌中的表达及其与卵巢癌发生发展的相关性研究 被引量:1

下载PDF
导出
摘要 目的研究Tlwist和z0.1在卵巢癌和正常卵巢组织中的表达及其分布特点,并探讨二者在卵巢癌表达中的相关性及其与肿瘤发生发展的关系。方法采用免疫组织化学方法(SP法)检测卵巢癌患者手术切除标本癌组织及正常卵巢组织中Tlwist和ZO-1的表达水平,并与肿瘤的分级和分期进行统计学分析。结果Twist在卵巢癌组织中阳性表达率(76.0%,38/50)高于正常卵巢组织(20.O%,4/20),差异有统计学意义(P〈O.05);ZO-1在卵巢癌组织中阳性表达率(32%,16/50)低于正常组织(85.0%,17/20),差异有统计学意义(P〈O.05);Twist和ZO·1的表达水平在卵巢癌的不同分级和分期中的表达差异有统计学意义(P〈O.05);二者在卵巢癌中的表达呈负相关(r=-0.76,P〈O.05)。结论Twist和ZO-1在卵巢癌组织中表达的变化可能与肿瘤的发生发展有关;Twist和ZO-1联合检测可作为评估卵巢癌转移与预后的指标。 Objective To investigate the expression and distribution &Twist and ZO-1 in epithelial ovarian cancer and to explore the correlation hetweenTwistandZO-1 in ovarian cancer. Methods lmmunohistoehemicalmethod (SPmethod) was used to detect the expression ofTwist and ZO-1 in 50 cases of ovarian cancer tissue and 20 cases of normal tissue of patient.The clinicopathologic characteristics and tumor staging were statistically analyzed. Results The positive rate of Twist was76.0% ( 38/50 ) in ovarian cancer, 20.0 % ( 4/20 ) in the normal tissue of other patients, There were significant differences ( P〈0.05 ) .The positive rate of ZO-1 was 32.0% ( 16/50 ) in ovarian cancer, significantly lower than that in the normal tissue 85.0% ( 17/20 ) ( P〈0.05 ) .The expression of Twist and ZO-1 were associated with tumor staging and grading in ovarian cancer patients ( P〈0.05 ) . There was a negative correlation between the expression of Twist and ZO-1 in ovarian cancer patients. Conclusions The the high express of Twist and low express of ZO-I may be concerned with the genesis and the development of human epithelial ovarian cancer.The combined detection of Twist and ZO-1 expression may be used in assessing the metasasis and predicting the clinical prognosis of adenocarcinoma ovarian cancer.
出处 《浙江临床医学》 2016年第8期1407-1409,共3页 Zhejiang Clinical Medical Journal
基金 湖北省十堰市太和医院院级基金项目(2014JJXM0024)
关键词 卵巢癌 TWIST ZO-1 表达 EOC Twist ZO-1 Expression
  • 相关文献

参考文献9

  • 1杨丽娜,吴娟,赵静,戴斌,杨红.Twist和VEGF在上皮性卵巢癌中的表达[J].西安交通大学学报(医学版),2015,36(3):341-344. 被引量:17
  • 2郭兴军,王敏,江建新,石程剑,胡均,黄焕军.ZO-1和Claudin-1在胆管癌中的表达及其意义[J].中华实验外科杂志,2014,31(8):1739-1741. 被引量:4
  • 3Aletti GD,Gallenberg MM,Cliby WA,et al. Current management strategies for ovarian cancer. Mayo Clin Proc, 2007,82(6):751-770.
  • 4Yilmaz M,Christofori G. EMT,the cytoskeleton,and cancer cell invasion.Cancer Metastasis Rev,2009,28(1) :15-33.
  • 5Federica C,Alberto R,Marco M.Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.Exp Cell R.es,2009,315(17) : 2982-2994.
  • 6Santisteban M,Reiman JM,Asiedu MK,et al.Immune- induced epithehal to mesenchymal transition in vivo generates breast cancer stem cells.Cancer Res,2009,69(7) : 2887-2895.
  • 7Hosono S,Kajiyama H,Terauchi M,et al.Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients.B RJ Cancer,2007,96(2) : 314-420.
  • 8Kang Y, Massague J. Epethelial-mesenchymal transitions:Twist in development and metastasis. Cell,2004,118(3): 277-279.
  • 9Dhawan P,Singh AB,Deane NG,et al.Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.J Clin Invest, 2005,115 (7): 1765 - 1776.

二级参考文献28

  • 1黄志强.肝门部胆管癌外科治疗面临的问题与出路[J].中华实验外科杂志,2004,21(7):773-775. 被引量:78
  • 2胡孟钧,徐航娣,魏建丽,郦秀芳,张春丽.子宫颈上皮内瘤变进展过程中Claudin-1的表达和意义[J].临床与实验病理学杂志,2007,23(5):629-630. 被引量:6
  • 3李秋霞,罗茂林,李茹柳,陈蔚文.紧密连接蛋白ZO-1研究概述[J].广州中医药大学学报,2007,24(6):523-526. 被引量:34
  • 4Blechacz B,Gores GJ.Cholangiocarcinoma:Advances in pathogenesis,diagnosis,and treatment[J].Hepatology,2008 ;48 (1):308-321.
  • 5SALEHI F,DUNFIELD L,PHILLIPS KP,et al.Risk factors for ovarian cancer:an overview with emphasis on hormonal factors[J].Toxicol Environ Health B Crit Rev,2008,11(3-4):301-321.
  • 6SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
  • 7KANG Y,MASSAGUE J.Epithelial-mesenchymal transitions:twist in development and metastasis[J].Cell,2004,118(3):277-279.
  • 8LEE JM,DEDHAR S,KALLURI R,et al.The epithelialmesenchymal transition:new insights in signaling,development,and disease[J].Cell Biol,2006,172(7):973-981.
  • 9WALLERAND H,ROBERT G,PASTICIER G,et al.The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers[J].Urol Oncol,2010,28(5):473-479.
  • 10YU L,LU S,TIAN J,et al.TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis[J].Oncol Rep,2012,27(2):416-422.

共引文献19

同被引文献13

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部